News & Analysis on Clinical Trial Services & Contract Research And Development
Medidata and Syapse have teamed up to develop a new suite of solutions, which will aim address precision medicine challenges and accelerate clinical research in oncology for trial sponsors.
News in brief
The San Diego-CA-based contract research, development, and manufacturing organization (CDMO), BioDuro, has announced a cooperation agreement with Porton Pharma Solutions.
Vical has dismissed 40 employees and abandoned a Phase III vaccine candidate in a reshuffle it says allows for greater resources on HSV-2 and antifungal trials.
An update to guidance on patient payments in clinical trials has been released by the US FDA, urging institutional review boards and investigators be wary of undue influence impacting subject consent.
Pharma packaging firm Marchesini Group has acquired 48% of its serialisation software partner SEA Vision and forged a long-term agreement worth €125m.
Lonza has attributed a record-breaking year to the addition of Capsugel along with continued high pharma and biotech demand.
The US FDA has recommended Aradigm Corporation conduct an additional Phase III trial before resubmitting a new drug application for Linhaliq.